Transcatheter Aortic Valve Implantation
37
12
13
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 37 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (37)
Comparison of Eligible TAVI-valves - Cohort B
Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice
Randomized Study of Physiological vs Right Ventricular Pacing in Patients With Normal Ventricular Function Post TAVI
Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
Remote Cardiovascular Monitoring in Post-TAVI Patients
Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management
NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population
Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+
The Sentinel Registry
TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics
Prevalence of Cusp Asymmetry, Coronary Ostial Eccentricity in Patients Undergoing Trans Catheter Aortic Valve Implantation and Their Impact on Coronary Ostia Overlap Risk Assessment
Registry of Aortic Valve Bioprostheses Established by Catheter
Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation
Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis
Comparison of Different Vascular Closure Device in TAVI
Reversibility of Cardiac Conduction Disturbances Following TAVI
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
Effectiveness of the NephroCheck™ After TAVI